Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer’s disease
Stephanie Lindgård Knudtzon(University Hospital of North Norway), Bjørn‐Eivind Kirsebom(University Hospital of North Norway), Ingvild Vøllo Eliassen(University of Oslo), Kaja Nordengen(Akershus University Hospital), Knut Waterloo(University Hospital of North Norway), Lene Pålhaugen(University of Oslo), Tormod Fladby(University of Oslo), Gøril Rolfseng Grøntvedt(St Olav's University Hospital), Jonas Alexander Jarholm(University of Oslo), Per Selnes(Akershus University Hospital), Jacob Espenes(University Hospital of North Norway), Berglind Gísladóttir(University of Oslo)
Cited by 5
Related Papers
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
|Nature Neuroscience|2019|1.7k
A Practical Guide to Immunoassay Method Validation
|Frontiers in Neurology|2015|541
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
|Nature Genetics|2015|332